Membrane interaction of calcium channel antagonists modulated by cholesterol: Implications for drug activity
- 9 June 1993
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (11) , 2173-2183
- https://doi.org/10.1016/0006-2952(93)90186-z
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channelNature, 1989
- Induction of calcium currents by the expression of the α1-subunit of the dihydropyridine receptor from skeletal muscleNature, 1989
- Photoaffinity labelling and phosphorylation of a 165 kilodalton peptide associated with dihydropyridine and phenylalkylamine-sensitive calcium channelsBiochemical and Biophysical Research Communications, 1987
- The 165‐KDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channelEuropean Journal of Biochemistry, 1987
- Primary structure of the receptor for calcium channel blockers from skeletal muscleNature, 1987
- What is the molecular nature of general anaesthetic target sites?Trends in Pharmacological Sciences, 1987
- Structural Analysis of Drug Molecules in Biological MembranesBiophysical Journal, 1986
- Rates of membrane-associated reactions: reduction of dimensionality revisited.The Journal of cell biology, 1986
- Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.Published by Elsevier ,1986
- Structure-function studies of canine cardiac sarcolemmal membranes. I. Estimation of receptor site densitiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985